{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:21:54Z","timestamp":1792142514326,"version":"4.4.0"},"reference-count":26,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"National Institute for Health Research (NIHR) Biomedical Research Fellowship, U.K","award":["BRF-2011-004"],"award-info":[{"award-number":["BRF-2011-004"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Hypoglycemia has been linked to persistent increases in cardiovascular (CV) mortality in type 2 diabetes after the event. Our aim was to examine acute and downstream effects of hypoglycemia on markers of thrombosis risk and inflammation in type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Twelve individuals with type 2 diabetes with no history of CV disease and 11 age- and BMI-matched volunteers without diabetes underwent paired hyperinsulinemic-euglycemic (glucose 6 mmol\/L for two 60-min periods) and hypoglycemic (glucose 2.5 mmol\/L for two 60-min periods) clamps on separate occasions on day 0. Fibrin clot properties, platelet reactivity, and inflammatory markers were measured at baseline, end of and after recovery from the initial clamp, day 1, and day 7 using validated assays and electron microscopy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Euglycemic hyperinsulinemia reduced platelet reactivity, decreased fibrin clot density, and improved fibrinolytic efficiency in both groups. Platelet reactivity and aggregation increased during acute hypoglycemia in both groups, resolving at recovery. In type 2 diabetes, clot lysis times and clot maximum absorbance increased up to day 7 (P = 0.002 and 0.001 vs. euglycemia, respectively), but clots from control subjects without diabetes showed limited changes. Fibrin network density increased \u0394 1.15 \u00b1 0.28 fibers\/\u03bcm2 at day 7 after the hypoglycemic clamp (P &amp;lt; 0.01 for glycemic arm), whereas fibrinogen and complement C3 increased after hypoglycemia up to day 7 in type 2 diabetes only.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Antecedent hypoglycemia has acute and persistent prothrombotic effects, lasting at least 7 days, that were enhanced in individuals with type 2 diabetes. These findings identify mechanisms by which hypoglycemia might increase short- and medium-term risk of CV mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-0050","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T17:45:32Z","timestamp":1539711932000},"page":"2625-2633","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":62,"title":["Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes"],"prefix":"10.2337","volume":"41","author":[{"given":"Elaine","family":"Chow","sequence":"first","affiliation":[{"name":"Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K."},{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K."},{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Walkinshaw","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K."},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fladia","family":"Phoenix","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Macdonald","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Nottingham, Nottingham, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Storey","sequence":"additional","affiliation":[{"name":"Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K."},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-3725","authenticated-orcid":false,"given":"Ramzi","family":"Ajjan","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-9565","authenticated-orcid":false,"given":"Simon R.","family":"Heller","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K."},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"2022031301184928800_B1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031301184928800_B2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031301184928800_B3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031301184928800_B4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"2022031301184928800_B5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/th14-02-0184","article-title":"Clot properties and cardiovascular disease","volume":"112","author":"Bridge","year":"2014","journal-title":"Thromb Haemost"},{"key":"2022031301184928800_B6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/diab.35.7.818","article-title":"Studies on mechanisms involved in hypoglycemia-induced platelet activation","volume":"35","author":"Trovati","year":"1986","journal-title":"Diabetes"},{"key":"2022031301184928800_B7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc10-0013","article-title":"Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes","volume":"33","author":"Wright","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301184928800_B8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc09-0354","article-title":"Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals","volume":"33","author":"Gogitidze Joy","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301184928800_B9","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2337\/db14-1729","article-title":"Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans","volume":"64","author":"Joy","year":"2015","journal-title":"Diabetes"},{"key":"2022031301184928800_B10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0038-1651130","article-title":"Hormonal control of haemostasis during hypoglycaemia in diabetes mellitus","volume":"57","author":"Grant","year":"1987","journal-title":"Thromb Haemost"},{"key":"2022031301184928800_B11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/cs0890359","article-title":"Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli","volume":"89","author":"Robinson","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"2022031301184928800_B12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/db08-1153","article-title":"Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control","volume":"58","author":"Adler","year":"2009","journal-title":"Diabetes"},{"key":"2022031301184928800_B13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031301184928800_B14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2337\/db16-1310","article-title":"Cardiac autonomic regulation and repolarization during acute experimental hypoglycemia in type 2 diabetes","volume":"66","author":"Chow","year":"2017","journal-title":"Diabetes"},{"key":"2022031301184928800_B15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301184928800_B16","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/ATVBAHA.107.153221","article-title":"Heritability of clot formation, morphology, and lysis: the EuroCLOT study","volume":"27","author":"Carter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031301184928800_B17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","article-title":"A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3","volume":"55","author":"Hess","year":"2012","journal-title":"Diabetologia"},{"key":"2022031301184928800_B18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2011-2894","article-title":"Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals","volume":"97","author":"Hooper","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301184928800_B19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bmj.310.6977.446","article-title":"Calculating correlation coefficients with repeated observations: part 1--correlation within subjects","volume":"310","author":"Bland","year":"1995","journal-title":"BMJ"},{"key":"2022031301184928800_B20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.0000116762.77804.FC","article-title":"Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction","volume":"109","author":"Chaudhuri","year":"2004","journal-title":"Circulation"},{"key":"2022031301184928800_B21","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.2337\/dc10-0929","article-title":"Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans","volume":"33","author":"Dandona","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301184928800_B22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-015-0207-2","article-title":"Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk","volume":"14","author":"Gajos","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"2022031301184928800_B23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00125-014-3267-z","article-title":"Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3","volume":"57","author":"Hess","year":"2014","journal-title":"Diabetologia"},{"key":"2022031301184928800_B24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1657180","article-title":"Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects","volume":"47","author":"Dalsgaard-Nielsen","year":"1982","journal-title":"Thromb Haemost"},{"key":"2022031301184928800_B25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","author":"Finfer","year":"2012","journal-title":"N Engl J Med"},{"key":"2022031301184928800_B26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/ATVBAHA.109.183707","article-title":"Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system","volume":"29","author":"Ajjan","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-0050","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/12\/2625\/527144\/dc180050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/12\/2625\/527144\/dc180050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T05:03:04Z","timestamp":1647147784000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/41\/12\/2625\/36524\/Prolonged-Prothrombotic-Effects-of-Antecedent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,10,16]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-0050","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}